Clinical trial · Observational
Feasibility of Non-Operative Management of Rectal Cancer in a Rural Population
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This is an observational research study. Patients with rectal cancer can choose different courses of treatment. This study will follow these patients over the course of approximately six years, depending on their treatment. Patients will be monitored through clinic visits and survey assessments to see how they do, how they feel regarding their treatment choices, and their outcomes. The surveys will analyze the impact of the patients' treatment choices, as well as patient adherence, in a rural setting.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Rectal Cancer | Malignant Rectal Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Bowel/rectal resection | Procedure | — | UNRESOLVED |
| non-operative follow up | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Operative Group
- description
- Patients who select operative treatment and follow up after successful neoadjuvant treatment.
- interventionNames
- Procedure: Bowel/rectal resection
- label
- Non-operative Group
- description
- Patients who select non-operative follow up after successful neoadjuvant treatment
- interventionNames
- Other: non-operative follow up
Primary outcomes (1)
- measure
- patient preferences for operative vs. non-operative management of rectal cancer
- timeFrame
- 8 months
- description
- Number of eligible patients who select operative versus non-operative management after successfully completing approximately 20 weeks of neoadjuvant treatment and the 10-12 week post treatment observation period
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: For a patient to be considered eligible for this study, ALL of the following conditions must be met: 1. Age 18 or greater 2. ECOG PS 0-2 3. Stage II or III, newly diagnosed, biopsy proven, rectal cancer 4. No prior treatment for rectal cancer 5. No prior pelvic radiotherapy 6. Willing to undergo study related testing and monitoring after treatment 7. Women of childbearing potential must rule out pregnancy within 2 weeks prior to registration with a blood test or urine study 8. Women must not be pregnant or breastfeeding 9. Able to provide informed consent Exclusion Criteria: Patients are NOT considered eligible for this study if any of the following conditions apply: 1. Patients with metastatic disease 2. Patients that are not candidates for surgery 3. Patients that refuse neoadjuvant treatment
References
Publications (0)
Data not yet available